Bloggers

Lisa Banket
Cofounding Partner/Publisher
VIEW MY COMPLETE PROFILE
Taren Grom
Cofounding Partner/Editor-in-Chief
VIEW MY COMPLETE PROFILE
Heather Hummel
Project Coordinator
VIEW MY COMPLETE PROFILE
Dan Limbach
Producer, Webcast Network
VIEW MY COMPLETE PROFILE
Denise Myshko
Managing Editor
VIEW MY COMPLETE PROFILE
Kim Ribbink
Features Editor
VIEW MY COMPLETE PROFILE
Robin Robinson
Senior Editor
VIEW MY COMPLETE PROFILE
Marah Walsh
Cofounding Partner/New Business Development
VIEW MY COMPLETE PROFILE

PharmaVOICE Editors' Blog

Showing posts with label life sciences. Show all posts
Showing posts with label life sciences. Show all posts

Friday, August 22, 2014

Upcoming Webinar: 10 Killer Applications for Digital Signatures in the Life Sciences Enterprise


Wednesday – October 1, 2014 / 01:00 pm EST/10am PT – Free Attendance
Sponsored by CoSign by ARX

Life sciences enterprises of all sizes are using digital signatures in a variety of ways across their business operation. They’re using this technology with their core quality management systems (QMS) and electronic document management systems (EDMS), as well as within various departments such as FDA-regulated clinical operations, manufacturing, field sales and service, research and discovery, and in non-FDA regulated back office applications.

Join us as we take a closer look at each of the 10 killer applications for digital signatures within a life sciences enterprise and uncover the tangible benefits that thousands of these enterprises are already enjoying. We’ll explore a number of real-world use cases involving these applications. Whether you’ve already deployed digital signatures within some of your departments or you’re still at the consideration stage, this webinar will be worth your while.

Topics include:
  • Defining standard digital signatures and their global acceptance in regulated applications
  • Considerations in using digital signatures for closed system applications throughout an enterprise for corporate governance
  • Strategies for deploying digital signatures in open systems for the front and middle office: collaboration and secure document exchange

Key Takeaways Include:
  • Discover new ways digital signatures can be used in the life sciences enterprise
  • Discover the value of digital signature automation for specific business processes
  • Learn the unique considerations for digital signatures in both closed and open systems from end-user case studies

Who Should Attend:
  • QA & Compliance
  • IT
  • COO
  • CIO
  • Department heads within: clinical operations, manufacturing, product management and project management


Thursday, May 8, 2014

Featured White Paper - Anticipating Success: Meeting the Inherent Challenges of Complex Drug Substances

PharmaVOICE Webcast Network

Throughout May, we are featuring an informative white paper provided by Vetter. The paper discusses the scientific and technical challenges that can crop up from the discovery phase to the commercial launch of a complex substance.

These challenges may be overcome with a systematic approach, which is consistent and repeatable.

You’ll learn about:
• The rise of injectables
• Patient-friendly delivery systems
• Optimizing yields
• Reducing overfilling
• Life cycle management
• 8 important questions that help avoid roadblocks

Download this free white paper now at http://bit.ly/0414vetterwp

PharmaVOICE Webcast Network

Wednesday, October 30, 2013

White Paper - Overcoming obstacles to transformation in the finance function

PharmaVOICE
Finance & Accounting in the Life Sciences
EVPs, SVPs, VPs and senior directors of targeted life sciences and pharmaceutical companies were surveyed to determine the key challenges and priorities facing finance and accounting (F&A), finance administration and commercial operations. This paper shares the results.

Download white paper

See All PharmaVOICE White Papers

Finance Life Science PharmaVOICE